Repligen (RGEN)

Repligen (RGEN)

Postby winston » Wed Oct 28, 2020 8:35 pm

not vested


Today, we're looking at a company that's aiding the fight against this pandemic...

As states have continued to reopen businesses, COVID-19 is still spreading. With more than 8.6 million cases and over 220,000 deaths in the U.S., medical companies are hurrying to develop a vaccine... But to do it as quickly and successfully as possible, they need devices, services, and chemical substances.

Today's company is helping researchers create and test vaccines efficiently...

Repligen (RGEN) is a $9 billion leader in bioprocess engineering. In broad terms, its products help companies make drugs that are based on living cells.

Repligen's technology has already helped narrow down an effective method for developing purified COVID-19 vaccines...

And the company reported record quarterly revenue of $87.5 million in the second quarter – totaling 24% year-over-year growth. That was partly due to a big uptick in orders related to COVID-19 vaccine development.

As you can see, after dipping in late February, RGEN soared nearly 110% to a new all-time high. As medical workers and companies continue to race for a COVID-19 vaccine, this uptrend should continue...

Source: Daily Wealth
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
Billionaire Boss
Posts: 109462
Joined: Wed May 07, 2008 9:28 am

Return to L to R

Who is online

Users browsing this forum: No registered users and 1 guest